氧化应激和内质网应激在癌症治疗中的鸡还是蛋的问题

M. Nikiforov
{"title":"氧化应激和内质网应激在癌症治疗中的鸡还是蛋的问题","authors":"M. Nikiforov","doi":"10.18143/JISANH_V3I3_1463","DOIUrl":null,"url":null,"abstract":"Cellular responses to oxidative and endoplasmic reticulum (ER) stress are among the most evolutionarily conserved pathways within the cell. Tumor cells commonly encounter both ER and oxidative stress due to high levels of metabolism, including increased rates of protein translation. Yet drugs aimed primarily at interference with these stress response pathways comprise only a small portion of currently available anti-neoplastic agents. Moreover, little is known about the interrelating connection between ER stress and oxidative stress caused by these few anticancer drugs. For instance, it is generally accepted that intracellular oxidative stress induced by proteasome inhibitors is a byproduct of ER stress.\nHere, we report a mechanism underlying the ability of proteasome inhibitor bortezomib (BTZ) to directly induce both oxidative and ER stress in multiple myeloma (MM) cells via transcriptional repression of the gene encoding mitochondrial thioredoxin reductase (TXNRD2). TXNRD2 is critical for maintenance of intracellular redox status and detoxification of reactive oxygen species.\nDepletion of TXNRD2 to the levels detected in BTZ-treated cells causes oxidative stress, ER stress and death similar to those induced by proteasome inhibitors. Reciprocally, restoration of near-wildtype TXNRD2 levels in MM cells treated with proteasome inhibitors reduces oxidative stress, ER stress and cell death by ~46%, ~35% and ~50%, respectively, compared to cells with depleted TXNRD2 levels. Moreover, cells from three MM cell lines selected for resistance to BTZ demonstrate elevated levels of TXNRD2, indirectly confirming its functional role in BTZ resistance.\nAccordingly, ectopic expression of TXNRD2 in MM cell xenografts in immunocompromised mice blunts the therapeutic effects of BTZ.\nOur data identifies TXNRD2 as a potential clinically relevant target, inhibition of which is critical for proteasome inhibitor-dependent cytotoxicity, oxidative stress, and ER stress.","PeriodicalId":17323,"journal":{"name":"Journal of the International Society of Antioxidants in Nutrition & Health","volume":"26 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2016-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"THE CHICKEN OR THE EGG QUESTION OF OXIDATIVE AND ENDOPLASMIC RETICULUM STRESSES IN CANCER THERAPY\",\"authors\":\"M. Nikiforov\",\"doi\":\"10.18143/JISANH_V3I3_1463\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Cellular responses to oxidative and endoplasmic reticulum (ER) stress are among the most evolutionarily conserved pathways within the cell. Tumor cells commonly encounter both ER and oxidative stress due to high levels of metabolism, including increased rates of protein translation. Yet drugs aimed primarily at interference with these stress response pathways comprise only a small portion of currently available anti-neoplastic agents. Moreover, little is known about the interrelating connection between ER stress and oxidative stress caused by these few anticancer drugs. For instance, it is generally accepted that intracellular oxidative stress induced by proteasome inhibitors is a byproduct of ER stress.\\nHere, we report a mechanism underlying the ability of proteasome inhibitor bortezomib (BTZ) to directly induce both oxidative and ER stress in multiple myeloma (MM) cells via transcriptional repression of the gene encoding mitochondrial thioredoxin reductase (TXNRD2). TXNRD2 is critical for maintenance of intracellular redox status and detoxification of reactive oxygen species.\\nDepletion of TXNRD2 to the levels detected in BTZ-treated cells causes oxidative stress, ER stress and death similar to those induced by proteasome inhibitors. Reciprocally, restoration of near-wildtype TXNRD2 levels in MM cells treated with proteasome inhibitors reduces oxidative stress, ER stress and cell death by ~46%, ~35% and ~50%, respectively, compared to cells with depleted TXNRD2 levels. Moreover, cells from three MM cell lines selected for resistance to BTZ demonstrate elevated levels of TXNRD2, indirectly confirming its functional role in BTZ resistance.\\nAccordingly, ectopic expression of TXNRD2 in MM cell xenografts in immunocompromised mice blunts the therapeutic effects of BTZ.\\nOur data identifies TXNRD2 as a potential clinically relevant target, inhibition of which is critical for proteasome inhibitor-dependent cytotoxicity, oxidative stress, and ER stress.\",\"PeriodicalId\":17323,\"journal\":{\"name\":\"Journal of the International Society of Antioxidants in Nutrition & Health\",\"volume\":\"26 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2016-07-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of the International Society of Antioxidants in Nutrition & Health\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.18143/JISANH_V3I3_1463\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the International Society of Antioxidants in Nutrition & Health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18143/JISANH_V3I3_1463","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

细胞对氧化和内质网(ER)应激的反应是细胞内最保守的进化途径之一。由于高水平的代谢,包括蛋白质翻译率的增加,肿瘤细胞通常会遇到内质网和氧化应激。然而,主要针对干扰这些应激反应途径的药物仅占目前可用的抗肿瘤药物的一小部分。此外,我们对内质网应激与这几种抗癌药物引起的氧化应激之间的相互关系知之甚少。例如,人们普遍认为蛋白酶体抑制剂诱导的细胞内氧化应激是内质网应激的副产物。在这里,我们报告了蛋白酶体抑制剂硼替佐米(BTZ)通过转录抑制编码线粒体硫氧还蛋白还原酶(TXNRD2)的基因,直接诱导多发性骨髓瘤(MM)细胞氧化应激和内质网应激的机制。TXNRD2对维持细胞内氧化还原状态和活性氧解毒至关重要。在btz处理的细胞中,TXNRD2消耗到检测到的水平会引起氧化应激、内质网应激和死亡,类似于蛋白酶体抑制剂引起的氧化应激、内质网应激和死亡。反过来,在蛋白酶体抑制剂处理的MM细胞中,恢复接近野生型的TXNRD2水平,与TXNRD2水平耗尽的细胞相比,分别减少了46%、35%和50%的氧化应激、内质网应激和细胞死亡。此外,三种MM细胞系的BTZ抗性细胞显示TXNRD2水平升高,间接证实了其在BTZ抗性中的功能作用。因此,TXNRD2在免疫功能低下小鼠MM细胞异种移植物中的异位表达减弱了BTZ的治疗作用。我们的数据确定TXNRD2是一个潜在的临床相关靶点,抑制它对蛋白酶体抑制剂依赖性细胞毒性、氧化应激和内质网应激至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
THE CHICKEN OR THE EGG QUESTION OF OXIDATIVE AND ENDOPLASMIC RETICULUM STRESSES IN CANCER THERAPY
Cellular responses to oxidative and endoplasmic reticulum (ER) stress are among the most evolutionarily conserved pathways within the cell. Tumor cells commonly encounter both ER and oxidative stress due to high levels of metabolism, including increased rates of protein translation. Yet drugs aimed primarily at interference with these stress response pathways comprise only a small portion of currently available anti-neoplastic agents. Moreover, little is known about the interrelating connection between ER stress and oxidative stress caused by these few anticancer drugs. For instance, it is generally accepted that intracellular oxidative stress induced by proteasome inhibitors is a byproduct of ER stress. Here, we report a mechanism underlying the ability of proteasome inhibitor bortezomib (BTZ) to directly induce both oxidative and ER stress in multiple myeloma (MM) cells via transcriptional repression of the gene encoding mitochondrial thioredoxin reductase (TXNRD2). TXNRD2 is critical for maintenance of intracellular redox status and detoxification of reactive oxygen species. Depletion of TXNRD2 to the levels detected in BTZ-treated cells causes oxidative stress, ER stress and death similar to those induced by proteasome inhibitors. Reciprocally, restoration of near-wildtype TXNRD2 levels in MM cells treated with proteasome inhibitors reduces oxidative stress, ER stress and cell death by ~46%, ~35% and ~50%, respectively, compared to cells with depleted TXNRD2 levels. Moreover, cells from three MM cell lines selected for resistance to BTZ demonstrate elevated levels of TXNRD2, indirectly confirming its functional role in BTZ resistance. Accordingly, ectopic expression of TXNRD2 in MM cell xenografts in immunocompromised mice blunts the therapeutic effects of BTZ. Our data identifies TXNRD2 as a potential clinically relevant target, inhibition of which is critical for proteasome inhibitor-dependent cytotoxicity, oxidative stress, and ER stress.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信